Sorafenib
Found 7 free book(s)
DRUG NAME: Sorafenib - BC Cancer
www.bccancer.bc.caSorafenib BC Cancer Agency Cancer Drug Manual© Page 1 of 7 Sorafenib Developed: 1 September 2007 Revised: 1 Jan 2010, 1 June 2013, 1 December 2014 DRUG NAME: Sorafenib
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
www.ema.europa.eu4 Hypertension An increased incidence of arterial hypertension was observed in sorafenib-treated patients. Hypertension was usually mild to moderate, occurred early in the course of treatment, and was
ANEXO I FICHA TÉCNICA O RESUMEN DE LAS …
www.ema.europa.euEn los pacientes tratados con sorafenib, se ha observado un incremento de la incidencia de hipertensión arterial. Habitualmente la hipertensión fue leve a moderada, se produjo al principio del tratamiento y fue
HIGHLIGHTS OF PRESCRIBING INFORMATION …
labeling.bayerhealthcare.comHIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use NEXAVAR safely and effectively. See full prescribing information for NEXAVAR.
Tyrosine Kinase Inhibitors for the Treatment of …
medcraveonline.comEndocrinology & Metabolism International Journal Tyrosine Kinase Inhibitors for the Treatment of Thyroid Cancer: Present and Future Volume 2 Issue 4 - 2015
Understanding Clinical Trial Data Through Use of ...
stat-computing.orgUnderstanding Clinical Trial Data Through Use of Statistical Graphics Will Bushnell Group Director GSK Oncology GlaxoSmithKline
BC CANCER HAZARDOUS DRUG LIST
www.bccancer.bc.caBC CANCER HAZARDOUS DRUG LIST (Refer to: Pharmacy Directive VI-80 Hazardous Drug List) The BC Cancer Hazardous Drug List (BC Cancer HD List) is comprised of: